Centessa Pharmaceuticals plc
CNTA
$39.60
-$0.02-0.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.64% | -1.80% | -11.87% | -41.00% | -7.00% |
| Total Receivables | 15.57% | 18.41% | -16.33% | 15.62% | 13.84% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -38.60% | 440.34% | -37.87% | -55.36% | -38.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 52.47% | 50.45% | -47.60% | 29.77% | -8.19% |
| Total Current Assets | 19.57% | 2.43% | -13.62% | -35.18% | -5.62% |
|
|
|||||
| Total Current Assets | 19.57% | 2.43% | -13.62% | -35.18% | -5.62% |
| Net Property, Plant & Equipment | -2.99% | -0.74% | -1.63% | -2.53% | -2.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.48% | -1.75% | -4.20% | -1.25% | -2.23% |
| Total Assets | 53.36% | -8.91% | -6.77% | -8.49% | -5.40% |
|
|
|||||
| Total Accounts Payable | -12.68% | 52.55% | 10.91% | -28.15% | -4.03% |
| Total Accrued Expenses | 77.53% | -15.46% | 36.15% | -65.83% | 174.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.24% | 4.27% | 4.29% | 4.49% | 4.33% |
| Total Finance Division Other Current Liabilities | -40.55% | -10.76% | -74.34% | 69.03% | 128.33% |
| Total Other Current Liabilities | -40.55% | -10.76% | -74.34% | 69.03% | 128.33% |
| Total Current Liabilities | 47.43% | -1.93% | 22.69% | -58.27% | 119.64% |
|
|
|||||
| Total Current Liabilities | 47.43% | -1.93% | 22.69% | -58.27% | 119.64% |
| Long-Term Debt | 0.25% | 0.25% | 0.27% | 0.29% | 43.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.40% | -2.28% | -2.16% | -2.06% | -1.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 9.48% | -0.33% | 3.96% | -19.20% | 58.49% |
|
|
|||||
| Common Stock & APIC | 20.53% | 0.75% | 0.68% | 0.94% | 0.85% |
| Retained Earnings | -5.91% | -5.15% | -4.96% | -2.64% | -12.69% |
| Treasury Stock & Other | 4.38% | 63.42% | -23.33% | -50.75% | 101.10% |
| Total Common Equity | 74.70% | -12.57% | -10.70% | -3.81% | -19.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 74.70% | -12.57% | -10.70% | -3.81% | -19.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 74.70% | -12.57% | -10.70% | -3.81% | -19.55% |
|
|
|||||